About Shanghai Doning Biotechnology
Shanghai Doning Biotechnology is a company based in Shanghai (China) founded in 2005. Shanghai Doning Biotechnology has raised $14.88 million across 3 funding rounds from investors including GL Capital, HongShan and Ally Bridge Group. Shanghai Doning Biotechnology has completed 1 acquisition, including PreFluid. Shanghai Doning Biotechnology operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.88 M (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
GL Capital
& 2 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has successfully raised a total of $14.88M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GL Capital, HongShan and Ally Bridge Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and hedge fund investments in healthcare are managed.
|
Locked | Locked | Locked | |
|
GL Capital is focused on healthcare sector value investments.
|
Locked | Locked | Locked | |
|
HongShan is engaged in venture capital investments for innovative companies.
|
Locked | Locked | Locked |
Investor details for Shanghai Doning Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shanghai Doning Biotechnology
Shanghai Doning Biotechnology has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PreFluid.
Investment portfolio details for Shanghai Doning Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Peristaltic pump solutions are supplied to pharmaceutical and chemical sectors.
|
Locked | Locked | 2007 | Locked |
Complete acquisition details for Shanghai Doning Biotechnology
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Shanghai Doning Biotechnology
Detailed financials for Shanghai Doning Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shanghai Doning Biotechnology Comparisons
Peer comparison for Shanghai Doning Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Shanghai Doning Biotechnology
Shanghai Doning Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| Locked | Locked | Locked |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of Shanghai Doning Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shanghai Doning Biotechnology
Complete news archive for Shanghai Doning Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shanghai Doning Biotechnology
Shanghai Doning Biotechnology was founded in 2005 and raised its 1st funding round 13 years after it was founded.
Shanghai Doning Biotechnology is headquartered in Shanghai, China.
Shanghai Doning Biotechnology is a funded company, having raised a total of $14.88M across 3 funding rounds to date.
Shanghai Doning Biotechnology was founded in 2005 in Shanghai, China. Serum-free cell culture media is provided by the company to biopharmaceutical sectors. Operations focus on products such as basic medium, feed medium, cell therapy medium, and one-time solutions. Services encompass personalized media development, cell culture process optimization, and commissioned formula production for customers.
Shanghai Doning Biotechnology's top competitors include Biocare Medical, Merck and Siemens Healthineers.
Shanghai Doning Biotechnology has made 1 acquisition, including PreFluid.
Shanghai Doning Biotechnology has 3 investors. Key investors include GL Capital, HongShan, and Ally Bridge Group.